Filter

51 - 60 of 372 Results

  • The Mexico City Policy: An Explainer

    Issue Brief

    Explore an overview of the Mexico City Policy, which, when in effect, requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving U.S. government global health assistance.

  • How Much Global Health Funding Goes Through USAID?

    Policy Watch

    This analysis highlights USAID's role in global health and shows that the agency provided the vast majority of the nation's global health assistance for other countries in 2023 (about $6.2 billion or 73% of the total bilateral global health funding that year).

  • Donor Government Funding for Family Planning in 2023

    Report

    This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2023, which totaled US$1.47 billion, and was an increase of 7% (US$101 million) compared to the 2022 amount (US$1.37 billion); although, it was still below the peak level reached in 2019 (US$1.58 billion). The overall increase was due to increased bilateral funding from most donor governments; multilateral funding (contributions to UNFPA’s core resources) declined slightly.

  • The U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria

    Fact Sheet

    This updated fact sheet examines the U.S. role in the Global Fund, an independent, multilateral financing entity that raises significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.

  • The Ground Has Shifted Under PEPFAR: What Does That Mean for Its Future?

    Perspective

    In this viewpoint article in the Journal of the International AIDS Society, KFF's Jennifer Kates and co-authors Brian Honermann and Gregorio Millett of amfAR explore the implications of shifts in the global economic and political environment for the future of PEPFAR, the U.S government's global HIV program created under President George W. Bush and credited with changing the trajectory of the global HIV/AIDS pandemic.

  • How HHS, FDA, and CDC Can Influence U.S. Vaccine Policy

    Policy Watch

    This policy brief highlights areas in which HHS, FDA, and CDC have authority to shape U.S. vaccine policy with a specific focus on vaccine approvals and recommendations for the public. Ultimately, while there are limits, federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the U.S. However, this does not include imposing mandates on or changing local vaccination requirements, as those authorities rest with state and local governments.